Pharma Reaserch Prod Co Ltd (214450) - Total Liabilities

Latest as of December 2025: ₩320.01 Billion KRW ≈ $216.87 Million USD

Based on the latest financial reports, Pharma Reaserch Prod Co Ltd (214450) has total liabilities worth ₩320.01 Billion KRW (≈ $216.87 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 214450 net assets growth trend to track the company's year-over-year net asset growth rate.

Pharma Reaserch Prod Co Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Pharma Reaserch Prod Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Pharma Reaserch Prod Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Pharma Reaserch Prod Co Ltd Competitors by Total Liabilities

The table below lists competitors of Pharma Reaserch Prod Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Pfizer Limited NSE:PFIZER	India	Rs7.19 Billion
Nektar Therapeutics NASDAQ:NKTR	USA	$187.06 Million
AstraZeneca PLC LSE:AZN	UK	GBX66.63 Billion
Zhejiang Publishing & Media Co Ltd SHG:601921	China	CN¥7.48 Billion
eToro Group Ltd. NASDAQ:ETOR	USA	$481.88 Million
Yantai Eddie Precision Mach SHG:603638	China	CN¥3.39 Billion
BRP Inc. NASDAQ:DOO	USA	$6.04 Billion
Kalpataru Projects International Ltd. NSE:KPIL	India	Rs199.80 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Pharma Reaserch Prod Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Pharma Reaserch Prod Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharma Reaserch Prod Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharma Reaserch Prod Co Ltd (2015–2025)

The table below shows the annual total liabilities of Pharma Reaserch Prod Co Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩320.01 Billion ≈ $216.87 Million	+11.79%
2024-12-31	₩286.26 Billion ≈ $193.99 Million	+291.67%
2023-12-31	₩73.09 Billion ≈ $49.53 Million	-45.68%
2022-12-31	₩134.55 Billion ≈ $91.18 Million	+10.10%
2021-12-31	₩122.20 Billion ≈ $82.82 Million	+64.23%
2020-12-31	₩74.41 Billion ≈ $50.43 Million	+22.28%
2019-12-31	₩60.85 Billion ≈ $41.24 Million	+0.47%
2018-12-31	₩60.56 Billion ≈ $41.04 Million	+494.87%
2017-12-31	₩10.18 Billion ≈ $6.90 Million	+32.38%
2016-12-31	₩7.69 Billion ≈ $5.21 Million	-38.76%
2015-12-31	₩12.56 Billion ≈ $8.51 Million	--

About Pharma Reaserch Prod Co Ltd

KQ:214450 Korea Biotechnology

Market Cap

$2.38 Billion

₩3.52 Trillion KRW

Market Cap Rank

#5515 Global

#118 in Korea

Share Price

₩338500.00

Change (1 day)

-2.73%

52-Week Range

₩259000.00 - ₩711000.00

All Time High

₩711000.00